AI Transparency Report
Surgical Review Corporation (SRC) demonstrates a concerning financial trend with persistent negative net assets, indicating that its liabilities consistently outweigh its assets. For instance, in 2023, assets were $86,086 while liabilities stood at $390,168. This suggests a reliance on debt or deferred revenue, which could pose long-term sustainability challenges. While the organization has shown revenue growth over the past decade, from $492,244 in 2014 to $5,005,574 in 2023, this growth has not translated into a robust asset base or positive net assets. The consistent reporting of 0% officer compensation across all filings is a positive indicator of executive compensation control and transparency regarding top salaries, though it's important to verify if this means no compensation or if it's reported elsewhere. The organization's NTEE code E05 suggests a focus on medical research and health, aligning with its name, but without detailed program expense breakdowns, it's difficult to fully assess spending efficiency.